Continue to hold longs from our previous recommendation.
Let's review the charts and indicators.
The shares could move to new highs provided the broader market doesn't start heading lower.
It might be best to wait for a pullback in shares of the diagnostic and testing company before buying.
Shares of the maker of life sciences equipment appear ready to head higher after a period of consolidation.
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
Has WBA rallied too much?
Buyers of the healthcare giant's shares have been more aggressive as the company pushes to launch its own Covid-19 vaccine.
MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.
T2 Biosystems and Tyme Technologies have both perked up of late after languishing for extended periods of time.